Pre-emptive psychiatric treatments: Pipe dream or a realistic outcome of clinical staging models?

Neuropsychiatry

Volumn 2, Issue 4, 2012, Pages 263-266

  Scott, Jan ^a,b   Hickie, Ian B ^c   McGorry, Pat ^d,e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c UNIVERSITY OF SYDNEY   (Australia)

^d THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENCE; ADULTHOOD; ARTHRITIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; GENERAL PRACTICE; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; NEUROIMAGING; NEUROPROTECTION; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIC TREATMENT; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SUICIDE; TREATMENT OUTCOME;

EID: 84876509695     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.12.32     Document Type: Review

References (15)

1. Insel T. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch. Gen. Psychiatry 66(2), 128-133 (2009).
2. McGorry PD. The recognition and optimal management of early psychosis: an evidencebased reform. World Psychiatry 1(2), 76-83 (2002).
3. McGorry PD, Yung AR, Phillips LJ et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 59(10), 921-928 (2002).
4. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. N. Z. J. Psychiatry 40(8), 616-622 (2006). (Pubitemid 43984963)
5. Fava GA, Kellner R. Staging: a neglected dimension in psychiatric classification. Acta Psychiatr. Scand. 87(4), 225-230 (1993). (Pubitemid 23107270)
6. Gonella J, Hornbrook M, Louis D. Staging of disease. A case-mix measurement. JAMA 251(5), 637-644 (1984). (Pubitemid 14221027)
7. Hickie I, Scott E, Hermens D et al. Applying clinical staging to young people who present for mental health care. Early Interv. Psychiatry doi:10.1111/j.1751-7893.2012.00366.x (2012) (Epub ahead of print).
8. Scott E, Hermens D, Glozier N, Naismith S, Guastella A, Hickie I. Targeted primary care-based mental health services engage young Australians in treatment. Med. J. Aust. 196, 136-140 (2012).
9. Berk M, Conus P, Lucas N et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 9(7), 671-678 (2007). (Pubitemid 350042401)
10. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35(3), 804-817 (2011).
11. Chong S, Subramaniam M, McGorry P. Preventive psychiatry. Ann. Acad. Med. Singapore 39(10), 747-749 (2010).
12. Kaur M, Battisti R, Lagopoulos J, Ward P, Hickie I, Hermens D. Neurophysiological biomarkers support bipolar-spectrum within psychosis cluster. J. Psychiatr. Neurosci. 37(3), 110081 (2012).
13. Conus P, McGorry PD. First-episode mania: a neglected priority for early intervention. Aust. N. Z. J. Psychiatry 36(2), 158-172 (2002). (Pubitemid 34746442)
14. Bechdolf A, Ratheesh A, Wood SJ et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr. Pharm. Des. 18(4), 358-375 (2012).
15. Scott J, Paykel E, Morriss R et al. Cognitivebehavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br. J. Psychiatry 188, 313-320 (2006).